Valproate Chrono Sanofi 300 mg

Valproate Chrono Sanofi 300 mg is a medicine authorised by Swissmedic under authorisation number 53112. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 September 1994 and the authorisation is valid without a time limit. ATC code N03AG01 places the medicine in the group Antiepileptics.

  • Dispensing category B
  • Authorisation number 53112
  • ATC N03AG01
  • Synthetic medicines
Authorisation data
Authorisation number53112
NameValproate Chrono Sanofi 300 mg
Full nameValproate Chrono Sanofi 300 mg, comprimés à libération prolongée
Authorisation holderSanofi-Aventis (Suisse) SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN03AG01
First authorisation05 September 1994
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
5Valproate Chrono Sanofi 300 mg, comprimés à libération prolongéeB29 April 2011
6Valproate Chrono Sanofi 500 mg, comprimés à libération prolongéeB29 April 2011

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
5100Tablette(n)N03AG0101.07.2.B
660Tablette(n)N03AG0101.07.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Valproate Chrono Sanofi 300 mg authorised in Switzerland?

Yes. Valproate Chrono Sanofi 300 mg is authorised by Swissmedic under authorisation number 53112, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Valproate Chrono Sanofi 300 mg have?

Valproate Chrono Sanofi 300 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Valproate Chrono Sanofi 300 mg?

The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com